Droplet Digital PCR (ddPCR) has been proven to be a sensitive method for detection of rare mutations from very limiting clinical samples, including liquid biopsy.
In particular, ddPCR simplifies multiplexing due to its partitioning of samples into thousands of droplet reactions for endpoint detection. This improves sensitivity, sample throughput and cost-savings in multiple biomarkers screening, which is necessary for accurate monitoring of therapy response and resistance.
In this webinar, join our expert panel as they discuss their experience of implementing advanced multiplex ddPCR strategies in the personalized management of cancer patients.
Wang Ji Dong, PhD,
Assistant Researcher
Shenzhen Nanshan People’s Hospital, China
Dr Wang Ji Dong has in-depth experience in cancer research and has successfully developed a multiplex droplet digital PCR assay for breast cancer subtype classification. He received his Masters in Fermentation Engineering at Tianjin University of Science and Technology and went on to attain his Ph.D in Physical Chemistry at the National Center for Nanoscience and Technology, University of Chinese Academy of Science. Dr Wang is currently an assistant researcher at Shenzhen Nanshan People's Hospital.
Dianna Maar, PhD,
Marketing Application Development Scientist
Bio-Rad Laboratories
Dr Dianna Maar obtained her PhD in Microbiology, Immunology and Molecular Genetics from UCLA. She has wide-ranging experience and understanding of virology, bacteriology, biofuels development, cancer, cell biology, PCR assay design and much more. She has worked on developing assays and applications for Droplet Digital PCR for over 8 years. Currently she is responsible for leading the Applications Development team at Bio-Rad’s Digital Biology Group in Pleasanton California. The applications team works on developing new applications for all things droplets including ddPCR and single cell genomics.
Alfred Chan, PhD,
Product Manager, Asia
Bio-Rad Laboratories
Dr Alfred Chan obtained his PhD in Molecular Biology from the University of Hong Kong. He has more than 10 years of experience in molecular biology, including digital PCR and Next Gen Sequencing. Dr Chan is currently Digital Biology Product Manager at Bio-Rad APAC. Prior to this, he was a post-doc scientist in Queen Mary Hospital, Hong Kong, and has also held various positions across different Life Science companies.